Articles From: Infinera Corporation Reports Second Quarter 2014 Financial Results to Information Architects to Acquire Legacy Animation Group LLC


Infinera Corporation (NASDAQ: INFN), provider of Intelligent Transport Networks , today released financial results for the second quarter of 2014 ended June 28, 2014.
Sign-up for Infinera Corporation Reports Second Quarter 2014 Financial Results investment picks
Mellanox® Technologies, Ltd.
Sign-up for InfiniBand Leads TOP500 as Most Used Interconnect Technology for High-Performance Computing investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company has purchased an option to buy out all future potential royalty payments due to Millennium: The Takeda Oncology Company for sales in oncology of IPI-145, Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma.
Sign-up for Infinity Amends PI3K-Delta, Gamma Agreement with Millennium investment picks
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 5, 2014, at 8:30 a.m. ET.
Sign-up for Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has entered into a master clinical supply agreement with Roche under which Roche will supply Gazyva TM (obinutuzumab) to Infinity for use in planned clinical studies to evaluate the combination of Gazyva and duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with hematologic malignancies, or blood cancers.
Sign-up for Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche investment picks
Shares of Infinity Pharmaceuticals (INFI) soared 46% in premarket trade Wednesday, after the company said it would receive an upfront payment of $275 million from AbbVie (ABBV) as part of a new collaboration to develop and commercialize Infinity's duvelisib, a treatment for blood cancers.
Sign-up for Infinity Pharmaceuticals shares soar after AbbVie collaboration investment picks
BIRMINGHAM, Ala.
Sign-up for Infinity Property And Casualty Corporation Declares Quarterly Dividend investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2014 financial results and ongoing progress with IPI-145 , an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma.
Sign-up for Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3 rd Annual Biotech Corporate Access Day on July 29, 2014.
Sign-up for Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following upcoming conferences: FBR Inaugural Healthcare Conference, Boston, MA, September 3 rd (no presentation or webcast) Morgan Stanley Healthcare Conference 2014, New York, September 8 th , at 11:40 a.m. ET A live webcast of Infinity's presentation at the Morgan Stanley Conference will be accessible on the “investors/media” section of the company's website, www.infi.com , and will be available for 30 days following each event.
Sign-up for Infinity to Participate in Two Conferences in September investment picks
2014/7/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133010&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for INFOBLOX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Infoblox, Inc. - BLOX investment picks
Infoblox Inc. (NYSE:BLOX), the network control company, today announced that its Infoblox Automation Solutions Architect (IASA) program has trained and certified more than 900 pre-sales engineers worldwide, less than two and a half years after the program’s launch.
Sign-up for Infoblox Announces More Than 900 Channel Professionals Have Completed Advanced Solutions Training investment picks
Infoblox Inc. (NYSE:BLOX) today announced the promotion of Thorsten Freitag to Executive Vice President, Worldwide Field Operations, effective October 1, 2014.
Sign-up for Infoblox Appoints Thorsten Freitag as Executive Vice President of Worldwide Field Operations investment picks
Infoblox Inc. (NYSE:BLOX), the network control company, today announced that it has enhanced the Infoblox IPAM Plug-in for VMware vCenter™ Orchestrator™, VMware vCloud Director ® , VMware vCloud ® Automation Center for Desktop and VMware vCloud ® Automation Center™ for Server, adding powerful new capabilities for DNS, DHCP, and IP address management (DDI) for private cloud networks.
Sign-up for Infoblox Enhances Network Control and Automated Provisioning of Network Resources for Private Clouds Running on VMware investment picks
Infoblox Inc. (NYSE:BLOX), the network control company, today announced that Infoblox IPv6 evangelist Tom Coffeen will give the keynote speech at the 7th annual North American IPv6 Technology Summit on Sept.
Sign-up for Infoblox Evangelist to Give Keynote Speech at 7th Annual North American IPv6 Technology Summit investment picks
Infoblox (NYSE:BLOX), the automated network control company, today reported its financial results for its fourth fiscal quarter ended July 31, 2014.
Sign-up for Infoblox Reports Fourth Quarter of Fiscal 2014 Results investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against Infoblox, Inc. (“Infoblox” or “Company”) (NYSE: BLOX) and several officers and directors for acts taken during the period of September 6, 2013 to February 10, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Infoblox.
Sign-up for Infoblox Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
SANTA CLARA, Calif., Aug.
Sign-up for Infoblox to Announce Fiscal Fourth Quarter 2014 Results investment picks
Infoblox (NYSE:BLOX), today announced participation in the following upcoming conferences with the financial community: A live audio web cast of the Deutsche Bank Technology Conference presentation will be accessible from the Investor Relations section of the corporate website at http://ir.infoblox.com .
Sign-up for Infoblox to Present at Upcoming Investment Conferences investment picks
Achieved over $1 billion of revenues in a 12-month period for the first time in company history Second quarter software revenues of $103.5 million, up 13 percent year-over-year Second quarter subscription revenues of $16.2 million, up 43 percent year-over-year Second quarter GAAP earnings per diluted share of $0.20, up 25% year-over-year, and non-GAAP earnings per diluted share of $0.35, up 13% year-over-year REDWOOD CITY, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA) , the world's number one independent provider of data integration software, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Informatica Reports Second Quarter Revenues of $250.7 Million investment picks
REDWOOD CITY, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA) , the world's number one independent leader in data integration software, today announced it will release its second quarter 2014 earnings results on July 24, 2014, after the close of the market.
Sign-up for Informatica Sets Date to Announce Second Quarter Earnings Results investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for Informatica to Present At 2014 Deutsche Bank Technology Conference investment picks
2014/6/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127193&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Information Architects Issues Letter to Shareholders investment picks
2014/6/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127096&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Information Architects to Acquire Legacy Animation Group LLC investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Infinera Corporation Reports Second Quarter 2014 Financial Results to Information Architects to Acquire Legacy Animation Group LLC
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices